Effect of front-line therapy with either high-dose therapy and autologous stem cell rescue (HDT/ASCR) or dose-intensive therapy (R-Hypercvad) on outcome in mantle cell lymphoma (MCL).

被引:3
|
作者
Feldman, T. [1 ]
Mato, A. R. [1 ]
Zielonka, T. [1 ]
Masood, A. [1 ]
Goldberg, S. [1 ]
Rowley, S. D. [1 ]
Donato, M. [1 ]
Siegel, D. S. [1 ]
Pecora, A. [1 ]
Goy, A. [1 ]
机构
[1] Hackensack Univ, Med Ctr, Hackensack, NJ USA
关键词
D O I
10.1200/jco.2010.28.15_suppl.8067
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
8067
引用
收藏
页数:1
相关论文
共 50 条
  • [31] High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma
    Ingen-Housz-Oro, S
    Bachelez, H
    Verola, O
    Lebbé, C
    Marolleau, JP
    Hennequin, C
    Dubertret, L
    Morel, P
    Gisselbrecht, C
    Brice, P
    BONE MARROW TRANSPLANTATION, 2004, 33 (06) : 629 - 634
  • [32] Mantle cell lymphoma (MCL):: Induction therapy with HyperCVAD/High-dose methotrexate and cytarabine (M-C) (±rituximab) improves results of autologous stem cell transplant in first remission.
    Vose, J.
    Loberiza, F.
    Bierman, P.
    Bociek, G.
    Armitage, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 424S - 424S
  • [33] The impact of disease status on the outcome of high-dose therapy (HDT) and autologous stem cell transplantation (ASCT) for peripheral T-Cell lymphoma (PTCL).
    Nademanee, Auaypom P.
    Zain, Jasmine M.
    Palmer, Joycelynne
    Tsai, Nicole
    Kogut, Neil Martin
    Krishnan, Arnrita
    Popplewell, Leslie
    Rodriguez, Roberto
    Smith, Eileen Patricia
    Forman, Stephen J.
    BLOOD, 2006, 108 (11) : 871A - 871A
  • [34] High-dose therapy for mantle cell lymphoma - the Nottingham experience
    Jones, SG
    Gilyead, M
    Russell, NH
    Haynes, AP
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 37 - 37
  • [35] Renal outcome in dose-intensive melphalan therapy and autologous stem cell transplantation for AL amyloidosis.
    Meier, P
    Bakr, M
    Frossard, V
    Rosselet, A
    Kovacsovics, T
    Burnier, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 669A - 669A
  • [36] HIGH DOSE THERAPY AND STEM CELL RESCUE IN MANTLE CELL LYMPHOMA: THE MCL0208 TRIAL FROM FONDAZIONE ITALIANA LINFOMI
    Clerico, M.
    Ferrero, S.
    Alessandria, B.
    De Luca, G.
    Grimaldi, D.
    Genuardi, E.
    Zaccaria, G. M.
    Drandi, D.
    Cavallo, F.
    Mantoan, B.
    Ghislieri, M.
    Hohaus, S.
    Musuraca, G.
    Scalzulli, P. R.
    Ghiggi, C.
    Tani, M.
    Gaidano, G.
    Volpetti, S.
    Cabras, G.
    Di Renzo, N.
    Merli, F.
    Vallisa, D.
    Michieli, M.
    Pascarella, A.
    Cortelazzo, S.
    Ladetto, M.
    HAEMATOLOGICA, 2021, 106 (10) : 18 - 18
  • [37] Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphoma
    Kang, T. Y.
    Rybicki, L. A.
    Bolwell, B. J.
    Thakkar, S. G.
    Brown, S.
    Dean, R.
    Sekeres, M. A.
    Advani, A.
    Sobecks, R.
    Kalaycio, M.
    Pohlman, B.
    Sweetenham, J. W.
    BONE MARROW TRANSPLANTATION, 2007, 40 (10) : 973 - 978
  • [38] Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphoma
    T Y Kang
    L A Rybicki
    B J Bolwell
    S G Thakkar
    S Brown
    R Dean
    M A Sekeres
    A Advani
    R Sobecks
    M Kalaycio
    B Pohlman
    J W Sweetenham
    Bone Marrow Transplantation, 2007, 40 : 973 - 978
  • [39] Treatment of mantle cell lymphoma with sequential high-dose therapy and stem cell transplantation.
    Dreger, P
    Held, H
    Sonnen, R
    Kuse, R
    Glass, B
    Uharek, L
    Zeis, M
    von Neuhoff, N
    Suttorp, M
    Schmitz, N
    BONE MARROW TRANSPLANTATION, 1998, 21 : S169 - S169
  • [40] Salvage therapy after high-dose therapy (HDT) and autologous stem cell transplantation (SCT): allogeneic or autologous second transplant in lymphoma, a retrospective analysis of the EBMT
    Glass, B
    de Elvira, CR
    Schmitz, N
    BONE MARROW TRANSPLANTATION, 2002, 29 : S10 - S10